Global COVID-19 IgG & IgM Rapid Test Cassette Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global COVID-19 IgG & IgM Rapid Test Cassette Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
COVID-19 testing can identify the SARS-CoV-2 virus and includes methods that detect the presence of virus itself (RT-PCR and isothermal nucleic acid amplification) and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for diagnosis and population surveillance. Antibody tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic. An accurate mortality rate of the disease and the level of herd immunity in the population can be determined from the results of this test. However, the duration and effectiveness of this immune response are still unclear.
COVID-19 IgG & IgM Rapid Test Cassette report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global COVID-19 IgG & IgM Rapid Test Cassette market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Hospitals and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for COVID-19 IgG & IgM Rapid Test Cassette industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, COVID-19 IgG & IgM Rapid Test Cassette key companies include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. Cellex, Abbott, Roche are top 3 players and held % share in total in 2023.
COVID-19 IgG & IgM Rapid Test Cassette can be divided into Rapid Diagnostic Test (RDT), Enzyme Linked Immunosorbent Assay (ELISA) and Neutralization Assay,, etc. Rapid Diagnostic Test (RDT) is the mainstream product in the market, accounting for % share globally in 2023.
COVID-19 IgG & IgM Rapid Test Cassette is widely used in various fields, such as Hospitals and Scientific Research, etc. Hospitals provides greatest supports to the COVID-19 IgG & IgM Rapid Test Cassette industry development. In 2023, global % share of COVID-19 IgG & IgM Rapid Test Cassette went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 IgG & IgM Rapid Test Cassette market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
Hospitals
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the COVID-19 IgG & IgM Rapid Test Cassette market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, COVID-19 IgG & IgM Rapid Test Cassette introduction, etc. COVID-19 IgG & IgM Rapid Test Cassette Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of COVID-19 IgG & IgM Rapid Test Cassette market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
COVID-19 IgG & IgM Rapid Test Cassette report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global COVID-19 IgG & IgM Rapid Test Cassette market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Hospitals and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for COVID-19 IgG & IgM Rapid Test Cassette industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, COVID-19 IgG & IgM Rapid Test Cassette key companies include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. Cellex, Abbott, Roche are top 3 players and held % share in total in 2023.
COVID-19 IgG & IgM Rapid Test Cassette can be divided into Rapid Diagnostic Test (RDT), Enzyme Linked Immunosorbent Assay (ELISA) and Neutralization Assay,, etc. Rapid Diagnostic Test (RDT) is the mainstream product in the market, accounting for % share globally in 2023.
COVID-19 IgG & IgM Rapid Test Cassette is widely used in various fields, such as Hospitals and Scientific Research, etc. Hospitals provides greatest supports to the COVID-19 IgG & IgM Rapid Test Cassette industry development. In 2023, global % share of COVID-19 IgG & IgM Rapid Test Cassette went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 IgG & IgM Rapid Test Cassette market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
Segment by Application
Hospitals
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the COVID-19 IgG & IgM Rapid Test Cassette market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, COVID-19 IgG & IgM Rapid Test Cassette introduction, etc. COVID-19 IgG & IgM Rapid Test Cassette Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of COVID-19 IgG & IgM Rapid Test Cassette market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices